Please login to the form below

Not currently logged in
Email:
Password:

American College of Cardiology

This page shows the latest American College of Cardiology news and features for those working in and with pharma, biotech and healthcare.

AZ’s Farxiga has no significant benefit for hospitalised COVID-19 patients

AZ’s Farxiga has no significant benefit for hospitalised COVID-19 patients

SGLT2 inhibitor failed to significantly reduce the number of patients who experienced organ failure or died compared to placebo. ... AstraZeneca’s (AZ) SGLT-2 inhibitor Farxiga showed no significant benefit for hospitalised COVID-19 patients, according

Latest news

  • Merck, Bayer flesh out vericiguat heart failure data at ACC Merck, Bayer flesh out vericiguat heart failure data at ACC

    The data were presented at the American College of Cardiology (ACC) conference – taking place for the first remotely because of the coronavirus pandemic – and also published in the New England Journal ... a form of heart failure that accounts for

  • Sanofi, Regeneron offer price cut for cholesterol drug Praluent Sanofi, Regeneron offer price cut for cholesterol drug Praluent

    The offer has been made just after the presentation of the large-scale ODYSSEY OUTCOMES at the American College of Cardiology (ACC) meeting in Orlando, which showed that adding PCSK9 inhibitor ... be acceptable for the drug – depending on the

  • AZ data suggest SGLT2 inhibitors can reduce heart failure risk AZ data suggest SGLT2 inhibitors can reduce heart failure risk

    The CVD-REAL study – presented at the American College of Cardiology (ACC) meeting in Washington DC - examined patient records from 300, 000 people across six countries and found that treatment with ... patients with type 2 diabetes at the lower end of

  • Xarelto beats aspirin for recurrent blood clots Xarelto beats aspirin for recurrent blood clots

    risk. The results of the EINSTEIN CHOICE trial looked at the value of extended treatment of patients with venous thromboembolism (VTE). ... The results were presented at the American College of Cardiology (ACC) meeting in Washington DC by Philip Wells of

  • Novartis launches heart failure social network Novartis launches heart failure social network

    To that end the company worked with several US health advocacy organisations to set up Together in HF, among them the American Association of Heart Failure Nurses, CardioSmart by the American ... College of Cardiology and WomenHeart: The National

More from news
Approximately 2 fully matching, plus 28 partially matching documents found.

Latest Intelligence

  • Treatment and prevention of cardiovascular disease Treatment and prevention of cardiovascular disease

    For individuals with diabetes, cardiovascular disease is the leading cause of morbidity and mortality. ... with omega-3 CA’, as reported by the American College of Cardiology on 15 November 2020.

  • Interview: Allan Hillgrove, Boehringer Interview: Allan Hillgrove, Boehringer

    This interest in China expands beyond Lilly and diabetes, however, and Boehringer's additional efforts include educational partnerships, such as a joint effort with the Chinese Society of Cardiology and the ... American College of Cardiology (ACC) to

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest appointments

  • New head at Cardiovascular Research Foundation New head at Cardiovascular Research Foundation

    Jack Lewin is former CEO of American College of Cardiology and the California Medical Association. ... A former CEO of both the American College of Cardiology and the California Medical Association, Lewin has also served as director of health for Hawaii,

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Six Degrees Medical Consulting

For over a decade, our medical communication services have helped pharmaceutical companies optimize their brand, disease and corporate objectives. Building...

Latest intelligence

What does the future hold for Light-chain Amyloidosis?
Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...
Webinar:
Securing a future for telehealth with immersive market research insights...
Accelerating patient recruitment in clinical trials with the Clinical Enrolment Managers (CEMs)
How Innovative Trials' global Clinical Enrolment Managers (CEMs) give clinical trial sites the local touch...